Samsara BioCapital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001744967

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 41 positions · Total reported value $642.80M · Top-10 concentration 78.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.0% · 3 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2023 13F filing, Samsara BioCapital, LLC disclosed 41 equity positions with a combined reported value of $642.80M. The filing implies a focused portfolio: its ten largest positions account for 78.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were SRRK ($127.63M), RYZB ($114.76M), CRGX ($95.42M). By sector, the heaviest allocations are Health Care 43.8%, Technology 0.4%. Versus the prior quarter, allocation shifted toward Other (+1.0pp) and away from Industrials (-1.1pp).

Versus the prior quarter, Samsara BioCapital, LLC opened 3 new positions, trimmed 7 and fully exited 0, a turnover rate of 37.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q4 2023 were CRGX ($95.42M), NGNE ($24.57M), ABVX ($9.10M).

Of the 3 positions fully exited versus the prior quarter, the largest were ICPT ($11.88M), IMCR ($4.20M), EYPT ($3.45M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • CRGX CARGO THERAPEUTICS INC · $95.42M
  • NGNE NEUROGENE INC · $24.57M
  • ABVX ABIVAX SA · $9.10M

Fully Exited (vs previous quarter)

  • ICPT INTERCEPT PHARMACEUTICALS IN · prev qtr: $11.88M
  • IMCR IMMUNOCORE HLDGS PLC · prev qtr: $4.20M
  • EYPT EYEPOINT INC · prev qtr: $3.45M

Insider Transactions (Form 4)

Latest Samsara BioCapital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Samsara BioCapital, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 27 positions worth $1.05B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • SEC registration: 801-113741 (status: Approved), registered 2018-07-27
  • Regulatory AUM (Form ADV): $2.17B as of 2026-10-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds

Portfolio Structure

  • 27 positions · $1.05B reported value (Q3 2026)
  • Top 10 holdings = 87.9% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 31.7%
  • Average position size: $38.95M

Sector Tilt

  • Health Care 91.8%
  • Industrials 8.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 3 new, 3 added, 7 reduced
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 43.8%
Technology 0.4%
Other 55.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.79M $127.63M 19.86%
19.86%
Add
2 1.85M $114.76M 17.85%
17.85%
Hold
3 4.12M $95.42M 14.84%
14.84%
New
4 4.52M $38.87M 6.05%
6.05%
Hold
5 460.44K $25.55M 3.98%
3.98%
Reduce
6 1.27M $24.57M 3.82%
3.82%
New
7 8.46M $22.16M 3.45%
3.45%
Hold
8 2.87M $18.93M 2.94%
2.94%
Hold
9 2.52M $18.82M 2.93%
2.93%
Add
10 1.46M $15.16M 2.36%
2.36%
Hold
11 2.78M $14.57M 2.27%
2.27%
Hold
12 1.79M $13.92M 2.17%
2.17%
Add
13 967.53K $13.66M 2.12%
2.12%
Hold
14 799.27K $12.83M 2.00%
2.00%
Hold
15 850.00K $9.10M 1.42%
1.42%
New
16 172.65K $7.94M 1.24%
1.24%
Reduce
17 1.68M $7.19M 1.12%
1.12%
Hold
18 347.50K $6.91M 1.07%
1.07%
Hold
19 3.64M $6.84M 1.06%
1.06%
Hold
20 1.56M $6.66M 1.04%
1.04%
Hold
21 630.00K $6.24M 0.97%
0.97%
Hold
22 6.13M $5.59M 0.87%
0.87%
Hold
23 396.00K $4.17M 0.65%
0.65%
Hold
24 470.30K $4.17M 0.65%
0.65%
Hold
25 360.41K $3.87M 0.60%
0.60%
Hold
26 436.81K $2.97M 0.46%
0.46%
Reduce
27 196.43K $2.87M 0.45%
0.45%
Hold
28 669.30K $2.77M 0.43%
0.43%
Add
29 2.03M $2.44M 0.38%
0.38%
Hold
30 202.35K $1.31M 0.20%
0.20%
Hold
31 154.66K $1.29M 0.20%
0.20%
Hold
32 1.05M $1.18M 0.18%
0.18%
Hold
33 696.17K $730.98K 0.11%
0.11%
Hold
34 40.89K $470.21K 0.07%
0.07%
Reduce
35 172.09K $469.80K 0.07%
0.07%
Hold
36 689.71K $393.13K 0.06%
0.06%
Hold
37 45.00K $240.30K 0.04%
0.04%
Reduce
38 78.13K $97.66K 0.01%
0.01%
Hold
39 82.34K $55.97K 0.01%
0.01%
Hold
40 133.33K $8.00K 0.00%
0.00%
Hold
41 100.00K $1.94K 0.00%
0.00%
Hold

FAQ

What did Samsara BioCapital, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, Samsara BioCapital, LLC reported 41 equity positions worth $642.80M in aggregate; its largest disclosed positions were SRRK ($127.63M), RYZB ($114.76M), CRGX ($95.42M).

How large is Samsara BioCapital, LLC's portfolio?

Samsara BioCapital, LLC reported $642.80M of long equity holdings across 41 positions as of 2023-Q4. Top-10 holdings account for 78.1% of reported value.

What is Samsara BioCapital, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/samsara-biocapital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →